Largest Swiss (SMI) Pharmaceuticals & Biotech Stocks by Market Cap

UPDATED Dec 21, 2024

Discover large cap Swiss Pharmaceuticals & Biotech companies that are on the SMI. These Pharmaceuticals & Biotech Companies are organised by Market Cap.

26 companies
CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield

ROG

Roche Holding
CHF 247.40-2.3%1.3%CHF 198.6bCHF 303.36PE18.6xE11.5%3.9%

NOVN

Novartis
CHF 86.72-1.2%2.2%CHF 173.4bCHF 102.84PE16.5xE7.0%3.7%

LONN

Lonza Group
CHF 531.00-0.3%50.2%CHF 38.4bCHF 636.90PE66.9xE23.4%0.8%

GALD

Galderma Group
CHF 97.007.5%n/aCHF 23.0bCHF 99.88PS6xE44.6%n/a

SDZ

Sandoz Group
CHF 37.140.2%34.7%CHF 16.3bCHF 43.50PS1.8xE34.9%1.2%

BANB

Bachem Holding
CHF 57.10-12.0%-11.5%CHF 4.3bCHF 83.57PE37.7xE17.9%1.4%

SFZN

Siegfried Holding
CHF 981.00-5.1%15.6%CHF 4.2bCHF 1,187.67PE32.7xE13.7%0.4%

DESN

Dottikon ES Holding
CHF 216.50-1.6%-5.7%CHF 3.0bCHF 350.00PE39.6xS16.4%0%

TECN

Tecan Group
CHF 197.50-4.1%-42.7%CHF 2.5bCHF 284.86PE25xE14.8%1.5%

SKAN

SKAN Group
CHF 75.202.6%-7.5%CHF 1.7bCHF 90.67PE52.4xE18.7%0.5%

COPN

Cosmo Pharmaceuticals
CHF 59.70-1.0%15.3%CHF 957.9mCHF 97.30PE14.8xE17.2%3.1%

PPGN

PolyPeptide Group
CHF 28.754.7%66.8%CHF 948.3mCHF 36.25PS3.1xE64.2%0%

KURN

Kuros Biosciences
CHF 20.10-2.9%443.2%CHF 755.2mn/aPS14.4xn/an/a

BSLN

Basilea Pharmaceutica
CHF 41.352.6%20.6%CHF 501.2mCHF 77.25PS3.4xE22.0%0%

MOLN

Molecular Partners
CHF 4.26-11.4%13.0%CHF 157.0mCHF 9.75PS26.2xE-1.9%n/a

NWRN

Newron Pharmaceuticals
CHF 8.05-12.5%81.7%CHF 156.6mCHF 14.39PS24.1xE56.5%n/a

XLS

Xlife Sciences
CHF 25.00-3.8%-49.5%CHF 143.5mn/aPE6.8xn/an/a

SANN

Santhera Pharmaceuticals Holding
CHF 10.4613.1%4.2%CHF 126.6mCHF 32.00PE2xE35.4%n/a

IDIA

Idorsia
CHF 0.63-53.1%-68.8%CHF 119.1mCHF 1.00PS1.6xE17.4%n/a

CURN

Curatis Holding
CHF 12.25-15.2%n/aCHF 60.6mCHF 20.00n/an/an/a

RLF

Relief Therapeutics Holding
CHF 4.3511.5%135.1%CHF 54.6mn/aPS6.3xn/an/a

ADXN

Addex Therapeutics
CHF 0.053-11.7%18.3%CHF 5.2mn/aPS8.8xE0.09%n/a

SPEX

Spexis
CHF 0.030%-37.2%CHF 3.9mn/aPS3.4xn/an/a

KNRS

Kinarus Therapeutics Holding
CHF 16.135.9%-66.7%CHF 3.9mn/an/an/an/a
Page 1 of 2